PROSTVAC: Clinical Trials

1 trial of PROSTVAC, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Completed 1

Follow PROSTVAC: new trials by email Literature Review of PROSTVAC trials Research Report on PROSTVAC

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Randomized, Double-blind, Phase 3 Efficacy Trial of PROSTVAC-V/F +/- GM-CSF in Men With Asymptomatic or Minimally Symptomatic Metastatic Castrate-Resistant Prostate Cancer
PROSTVAC-V, PROSTVAC-F, GM-CSF - Prostate Cancer Metastatic
Phase 3CompletedBavarian Nordic12972011-11-282019-09-04

Conditions studied

Neoplasm Metastasis (1)  ·  Prostatic Neoplasms (1)

Sponsors

Bavarian Nordic (1)

Countries

Australia (1)  ·  Belgium (1)  ·  Canada (1)  ·  Denmark (1)  ·  Estonia (1)  ·  France (1)  ·  Germany (1)  ·  Iceland (1)  ·  Israel (1)  ·  Netherlands (1)  ·  Poland (1)  ·  Puerto Rico (1)  ·  Russia (1)  ·  Spain (1)  ·  United Kingdom (1)

Top investigators

James L. Gulley, MD (1)  ·  Philip Kantoff, MD (1)

Results publications

PMID 30817251